On 24 Mar 2009, at 13:49, eric neumann wrote: > I think this discussion has been quite useful and important, since > there are some remaining issues to be clarified by this community. > I think all points raised are good, but not equally valid. Bijan > and Phil's thoughts are very useful for me, and would probably > resonate within the informatics groups at pharma companies. > > I think a key guidance principle here is to ensure that whatever is > proposed "makes sense and works with molecular > biologists" (scientists). Perhaps existing information resources > need a major "enhancement" in order to work in a semantic web, but > then let's make it quite clear (to all possible users) what the > readily perceivable value of all these ontological adjustments will > be. BTW, I'm perfectly happy, albeit not until summer, to do various sorts of empirical research to help ground this discussion. I've done surveys fo the web and user studies before. I would be interested in knowing what sorts of questions would help people make decisions. In this sense I *am* all about the data :) Cheers, Bijan.Received on Tuesday, 24 March 2009 14:17:33 GMT
This archive was generated by hypermail 2.2.0+W3C-0.50 : Tuesday, 24 March 2009 14:17:33 GMT